Abiopharma

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: DURECT Corporation - Common Stock. New value: DURECT Corporation - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock. New value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Cyclacel Pharmaceuticals, Inc. - Common Stock. New value: Cyclacel Pharmaceuticals, Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: DURECT Corporation - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.